John McGinness

John Edward McGinness (born November 19, 1943), is an American physicist and physician. McGinness worked in the fields of organic electronics and nanotechnology.

Education

McGinness studied physics at the University of Houston, and after his B.S. in 1966 he received his PhD in Nuclear Physics, Material Science, and Space Science at Rice University in 1970.

He received his MD from the University of Texas Health Science Center at Houston (UTHealth) in 1985 and worked in internal medicine for one year, changing to psychiatry and working at the Department of Psychiatry, UTHealth, from 1989 to 1992. He authored roughly 40 research publications, book chapters, and presentations.

Work John McGinness materially contributed to the modern field of organic electronics. An organic polymer voltage-controlled switch from 1974. Now in the Smithsonian Chip collection

In 1972, while working at the Metallurgy department at Youngstown State University, McGinness suggested that electronic conduction in melanins (polyacetylene, polypyrrole, and polyaniline "blacks" and their copolymers) is analogous to conduction in amorphous solids such as the chalcogenide glasses. This area was originally pioneered by Sir Nevill Mott, among others. That is, it involves such things as mobility gaps, phonon-assisted hopping, polarons, quantum tunneling, and so forth.

From Youngstown, McGinness moved to the Physics Department of The University of Texas M. D. Anderson Cancer Center. The department had an interest in the physical properties of melanin as a possible hook to treating melanoma. While of enormous importance now, this area was a research backwater at the time. With the notable exception of Bolto et al., who had reported high conductivity in iodine-doped polypyrrole, They also further characterized its electronic behavior.

Since he was at a cancer research institute, McGinness' other interests included the role of free radicals in the action and toxicity of the anticancer drugs cisplatin, adriamycin, and bleomycin. He was the first to show that the kidney toxicity of cisplatin involves reactive oxygen species. This was related to the future development of magnetic resonance imaging.